Role of oxidative stress-induced systemic and cavernosal molecular alterations in the progression of diabetic erectile dysfunction

Journal of Diabetes

Volumn 7, Issue 3, 2015, Pages 393-401

  Castela, Angela ^a,b   Gomes, Pedro ^a   Domingues, Valentina F ^c   Paíga, Paula ^c   Costa, Raquel ^a   Vendeira, Pedro ^d   Costa, Carla ^a  

^a University of Porto   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c INSTITUTO SUPERIOR DE ENGENHARIA DO PORTO   (Portugal)

^d Clínica Urológica Vendeira   (Portugal)

Author keywords

3 nitrotyrosine; Diabetes; Endothelial nitric oxide synthase; Erectile dysfunction; Oxidative stress

Indexed keywords

3 NITROTYROSINE; ALPHA SMOOTH MUSCLE ACTIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HYDROGEN PEROXIDE; 3-NITROTYROSINE; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; ENDOTHELIUM; ERECTILE DYSFUNCTION; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; SMOOTH MUSCLE; ANALOGS AND DERIVATIVES; ANIMAL; CELL CULTURE; COMPLICATION; EXPERIMENTAL DIABETES MELLITUS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOBLOTTING; METABOLISM; PATHOLOGY; PENIS; SMOOTH MUSCLE CELL; VASCULAR ENDOTHELIUM; WISTAR RAT;

ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; ERECTILE DYSFUNCTION; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOBLOTTING; MALE; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PENIS; RATS; RATS, WISTAR; TYROSINE;

EID: 84928213521     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12181     Document Type: Article

References (32)

1. Bortolotti A, Parazzini F, Colli E, Landoni M. The epidemiology of erectile dysfunction and its risk factors. Int J Androl. 1997; 20: 323-334.
2. Saenz de Tejada I, Angulo J, Cellek S etal. Pathophysiology of erectile dysfunction. J Sex Med. 2005; 2: 26-39.
3. Rosen RC, Fisher WA, Eardley I, Niederberger C, Nadel A, Sand M. The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin. 2004; 20: 607-617.
4. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414: 813-820.
5. Newsholme P, Haber EP, Hirabara SM etal. Diabetes associated cell stress and dysfunction: Role of mitochondrial and non-mitochondrial ROS production and activity. J Physiol. 2007; 583: 9-24.
6. Agarwal A, Nandipati KC, Sharma RK, Zippe CD, Raina R. Role of oxidative stress in the pathophysiological mechanism of erectile dysfunction. J Androl. 2006; 27: 335-347.
7. Bivalacqua TJ, Usta MF, Kendirci M etal. Superoxide anion production in the rat penis impairs erectile function in diabetes: Influence of in vivo extracellular superoxide dismutase gene therapy. J Sex Med. 2005; 2: 187-197.
8. Saenz de Tejada I, Anglin G, Knight JR, Emmick JT. Effects of tadalafil on erectile dysfunction in men with diabetes. Diabetes Care. 2002; 25: 2159-2164.
9. Tuncayengin A, Biri H, Onaran M etal. Cavernosal tissue nitrite, nitrate, malondialdehyde and glutathione levels in diabetic and non-diabetic erectile dysfunction. Int J Androl. 2003; 26: 250-254.
10. Zhang Q, Radisavljevic ZM, Siroky MB, Azadzoi KM. Dietary antioxidants improve arteriogenic erectile dysfunction. Int J Androl. 2011; 34: 225-235.
11. Bivalacqua TJ, Musicki B, Usta MF etal. Endothelial nitric oxide synthase gene therapy for erectile dysfunction. Curr Pharm Des. 2005; 11: 4059-4067.
12. Yu W, Wan Z, Qiu XF, Chen Y, Dai YT. Resveratrol, an activator of SIRT1, restores erectile function in streptozotocin-induced diabetic rats. Asian J Androl. 2013; 15: 646-651.
13. Vincent AM, Russell JW, Low P, Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev. 2004; 25: 612-628.
14. Radi R. Protein tyrosine nitration: Biochemical mechanisms and structural basis of functional effects. Acc Chem Res. 2013; 46: 550-559.
15. Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci U S A. 2004; 101: 4003-4008.
16. Pacher P, Obrosova IG, Mabley JG, Szabo C. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem. 2005; 12: 267-275.
17. Ceriello A, Mercuri F, Quagliaro L etal. Detection of nitrotyrosine in the diabetic plasma: Evidence of oxidative stress. Diabetologia. 2001; 44: 834-838.
18. Fan M, Xu X, He X etal. Protective effects of hydrogen-rich saline against erectile dysfunction in a streptozotocin induced diabetic rat model. J Urol. 2012; 190: 350-356.
19. Castela A, Soares R, Rocha F, Vendeira P, Virag R, Costa C. Erectile tissue molecular alterations with aging: Differential activation of the p42/44 MAP kinase pathway. Age (Dordr). 2011; 33: 119-130.
20. Costa C, Soares R, Castela A etal. Increased endothelial apoptotic cell density in human diabetic erectile tissue: Comparison with clinical data. J Sex Med. 2009; 6: 826-835.
21. Castela A, Soares R, Rocha F etal. Differentially expressed angiogenic genes in diabetic erectile tissue: Results from a microarray screening. Mol Genet Metab. 2012; 105: 255-262.
22. Yuen JW, Benzie IF. Hydrogen peroxide in urine as a potential biomarker of whole body oxidative stress. Free Radic Res. 2003; 37: 1209-1213.
23. Asaba K, Tojo A, Onozato ML etal. Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int. 2005; 67: 1890-1898.
24. Masella R, Di Benedetto R, Vari R, Filesi C, Giovannini C. Novel mechanisms of natural antioxidant compounds in biological systems: Involvement of glutathione and glutathione-related enzymes. J Nutr Biochem. 2005; 16: 577-586.
25. Ruperez FJ, Garcia-Martinez D, Baena B etal. Evolution of oxidative stress parameters and response to oral vitamins E and C in streptozotocin-induced diabetic rats. J Pharm Pharmacol. 2008; 60: 871-878.
26. Kanazawa A, Nishio Y, Kashiwagi A, Inagaki H, Kikkawa R, Horiike K. Reduced activity of mtTFA decreases the transcription in mitochondria isolated from diabetic rat heart. Am J Physiol Endocrinol Metab. 2002; 282: E778-785.
27. Onozato ML, Tojo A, Goto A, Fujita T, Wilcox CS. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB. Kidney Int. 2002; 61: 186-194.
28. Jin HR, Kim WJ, Song JS etal. Functional and morphologic characterizations of the diabetic mouse corpus cavernosum: Comparison of a multiple low-dose and a single high-dose streptozotocin protocols. J Sex Med. 2009; 6: 3289-3304.
29. De Young L, Yu D, Bateman RM, Brock GB. Oxidative stress and antioxidant therapy: Their impact in diabetes-associated erectile dysfunction. J Androl. 2004; 25: 830-836.
30. Jin HR, Kim WJ, Song JS etal. Intracavernous delivery of a designed angiopoietin-1 variant rescues erectile function by enhancing endothelial regeneration in the streptozotocin-induced diabetic mouse. Diabetes. 2011; 60: 969-980.
31. Pitocco D, Zaccardi F, Di Stasio E etal. Oxidative stress, nitric oxide, and diabetes. Rev Diabet Stud. 2010; 7: 15-25.
32. Liu G, Sun X, Dai Y etal. Chronic administration of sildenafil modified the impaired VEGF system and improved the erectile function in rats with diabetic erectile dysfunction. J Sex Med. 2010; 7: 3868-3878.